¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Postprocedural disorders of digestive system, NEC"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • parasympathetic nervous system
    ºÎ±³°¨½Å°æ°èÅë, ºÎ±³°¨½Å°æ°è
  • peripheral nervous system
    ¸»ÃʽŰæ°èÅë, ¸»ÃʽŰæ°è
  • renin-angiotensin-aldosterone system
    ·¹´Ñ-¾ØÁö¿ÀÅÙ½Å-¾Ëµµ½ºÅ׷аèÅë
  • reproductive system
    »ý½Ä°èÅë, »ý½Ä°è
  • respiratory system
    È£Èí°èÅë, È£Èí°è
  • reticuloendothelial system
    ±×¹°³»ÇǰèÅë, ¸Á»ó³»Çǰè
  • review of system
    ü°èº°¹®Áø
  • Rh blood group system
    RhÇ÷¾×Çüü°è
  • somatosensory system
    ¸ö°¨°¢°èÅë, ü¼º°¨°¢°è
  • static system
    Á¤Áö°è
  • scavenging system
    Á¦°Åü°è, û¼Òü°è
  • stereotactic system
    1. Á¤À§°íÁ¤±â 2. Á¤À§Ã¼°è, ÀÔüü°è
  • superficial musculo-aponeurotic system
    ¾ó±¼³ÎÈûÁÙ°èÅë, Ç¥Àç±Ù°Ç¸·°èÅë
  • superficial musculo-aponeurotic system platysma flap
    ¾ó±¼³ÎÈûÁÙ°èÅë³ÐÀº¸ñ±ÙÆÇ, Ç¥Àç±Ù°Ç¸·°èÅëȰ°æ±ÙÆÇ
  • system
    1. °èÅë, °è, ü°è 2. ÀåÄ¡ 3. Á¦µµ, ¹ý 4. ºÐ·ù¹ý
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • information system
    Á¤º¸Ã¼°è
  • infusion-aspiration system
    ÁÖÀÔÈíÀÔÀåÄ¡
  • integumentary system
    ÇǺΰèÅë
  • interofective system
    ³»ºÎȯ°æÁ¶Àý°è
  • interrenal system
    ºÎ½Å°ÑÁú°è
  • intrarenal collecting system
    ÄáÆÏ¼ÓÁý´¢°è
  • irrigation-aspiration system
    °ü·ùÈíÀÔÀåÄ¡
  • limbic system
    °¡ÀåÀÚ¸®°èÅë, º¯¿¬°è
  • local health system
    Áö¹æÀÇ·áü°è
  • lymphatic system
    ¸²ÇÁ°èÅë
  • macrophage system
    Å«Æ÷½Ä¼¼Æ÷°èÅë
  • major histocompatibility system
    ÁÖÁ¶Á÷ÀûÇÕ°è
  • metric system
    ¹ÌÅ͹ý
  • monocyte-macrophage cell system
    ´ÜÇÙ±¸Å«Æ÷½Ä¼¼Æ÷°èÅë
  • musculoskeletal system
    ±ÙÀ°°ñ°Ý°èÅë
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • genital system
    »ý½Ä°èÅë
  • genital system
    »ý½Ä±â°è(ßæãÖÐïͧ)
  • genitourinary system
    ºñ´¢»ý½Ä±â°èÅë(ù²èñßæãÖÐïͧ÷Ö).
  • genitourinary system
    ºñ´¢»ý½Ä±â°èÅë(ù²èñßæãÖÐïͧ÷Ö).
  • glial cell of central nervous system
    ÁßÃ߾Ʊ³¼¼Æ÷
  • glial cell of peripheral nervous system
    ¸»ÃʾƱ³¼¼Æ÷
  • global budget system
    ÃѾ׿¹»êÁ¦, ÃѾװè¾àÁ¦.
  • guarantee system
    º¸ÁõÁ¦µµ(ËÓ̡̡̬).
  • h2o2-myeloperxidase-halide system
    °ú»êÈ­¼ö¼Ò-°ñ¼ö°ú»êÈ­È¿¼Ò-ÇÒ·Î°Õ °èÅë
  • hamatopoietic system
    Á¶Ç÷±â°ü(ðãúìÐïί)
  • health care delivery system
    ÀÇ·áÀü´ÞÁ¦µµ(ËöËíËøËÀ̡̬).
  • health care system
    º¸°ÇÀÇ·áü°è.
  • health information system
    º¸°ÇÁ¤º¸Ã¼°è.
  • heterogeneous system
    ºÒ±ÕÀϰè, ºÒ±ÕÁú°è.
  • hexagonal system
    À°¹æ°áÁ¤°è.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • temperature-dependent skin disorders
    ¿ÂµµÀÇÁ¸ ÇǺκ´
  • tobacco-related disorders
    Åä¹ÙÄÚ(´ã¹è)°ü·ÃÀå¾Ö(~º´).
  • topographic localization disorders
  • voice disorders, organic
    ±âÁú(Àû) À½¼ºÀå¾Ö
  • voice disorders, psychogenic
    ½ÉÀÎ(¼º) À½¼ºÀå¾Ö
  • x linked disorders
    X¿¬°ü(XÀÇÁ¸)Àå¾Ö, X¿¬°üÁúº´
  • achromatic system
    ¹«»ö°è.
  • acid-base buffer system
    »ê¿°±â¿ÏÃæ°è
  • adrenal medulla,tumor of chemoreceptor system
    È­Çмö¿ëü°è Á¾¾ç(ûùùÊáôé»ô÷ͧ ðþåË)
  • adrenal system
    ºÎ½Å°è(Üùãìͧ).
  • aerospace life support system
    (Ç×°ø)¿ìÁÖ¿ë »ý¸íÀ¯Áö½Ã½ºÅÛ.
  • affectional system
    Á¤µ¿Ã¼°è
  • alimentary system(tract)
    ¼ÒÈ­±â°è(á¼ûùÐïͧ)
  • anaerobic culture system
    ¹«»ê¼Ò¹è¾çÀåÄ¡, ¹«»ê¼Ò¹è¾ç±â, ¹«»ê¼ÒÀåÄ¡
  • ancillary immune system
    º¸Á¶Àû ¸é¿ª°è
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 6
CELDIC Commission on Emotional and Learning Disorders in Children
DDRT diseases, disorders and related topics
DIMS disorders of initiating and maintaining sleep
DOC date of conception; deoxycholate; deoxycorticosterone; died of other causes; disorders of cornificat...
DOES disorders of excessive sleepiness
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 6
SCID II Structured Clinical Interview for DSM-III-R Personality Disorders
SIDP Structured Interview for DSM III Personality Disorders
SUD Substance Use Disorders
TMD Temporo Mandibular Disorders
TMD Temporomandibular joint disorders
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • metric system
    ¹ÌÅ͹ý
  • microsomal enzyme system
    ¹Ì¼Òü È¿¼Ò°è
  • monochromatic system
    ´Ü»ö°è
  • monocyte-macrophage system
    ´ÜÇÙ±¸-´ë½Ä ¼¼Æ÷°è
  • monovalent system
    ÀϺ¯°è
  • motor system disease
    ¿îµ¿°è Àå¾Ö
  • multiaxial diagnostic system
    ´ÙÃ༺ Áø´Ü ü°è
  • muscular system
    ±ÙÀ° °èÅë, ±Ù°è
  • natural color system
    õ¿¬»ö°è
    ¾Ø´õ½º Çϵ尡 °í¾ÈÇÑ »ö¼ø¹ý. 3¿ø¼Ò·Î ³ª´« »öÀÇ Ã¼°è ³»¿¡¼­ ºûÀÇ Â£°í ¿¶Àº Á¤µµ¸¦ ¿©¼¸ °¡Áö »öÀ» ÀÎÁöÇØ ºñÀ²ÀÇ °³³äÀ¸·Î ºÐ¼®ÇÏ´Â ¹æ¹ýÀÌ´Ù.
  • nervous system
    ½Å°æ°è
    ½ÅüÀÇ ÀÚ±ØÀ» ¼öÁýÇÏ¿© À̸¦ Àü±âÀû ÀÚ±ØÀ¸·Î º¯È¯Çؼ­ ÁßÃß ½Å°æ°è·Î º¸³» Á¾ÇÕÇÏ¿© ÀûÀýÇÑ ¹ÝÀÀ°ú °¨°¢À» ³ªÅ¸³½´Ù.
  • neural enzyme system
    ½Å°æ È¿¼Ò°è
  • neuromuscular system
    ±Ù½Å°æ°è, ½Å°æ ±ÙÀ°°è
  • non-noxious cutaneous stimulation system
    ºñÀ¯Çؼº ÇǺΠÀڱذè
  • non-painful cutaneous stimulation system
    ºñÅëÁõ¼º Àڱذè
  • non-specific arousal system
    ºñƯÀ̼º °¢¼º°è
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
speech disorders Long-term disorders in speaking or in perception of speech.
(12 Dec 1998)
necrobiotic disorders A group of disorders characterised by swelling, basophilia, and distortion of collagen bundles in the dermis.
(12 Dec 1998)
neurotic disorders Disorders in which the symptoms are distressing to the individual and recognised by him or her as being unacceptable. Social relationships may be greatly affected but usually remain within acceptable limits. The disturbance is relatively enduring or recurrent without treatment.
(12 Dec 1998)
stress disorders, posttraumatic Anxiety disorders manifested by the development of characteristic symptoms following a psychologically traumatic event that is outside the normal range of usual human experience. Symptoms include re-experiencing the traumatic event and numbing of responsiveness to or reduced involvement with the external world.
(12 Dec 1998)
substance abuse disorders A class of mental disorders in which behavioural and biological changes are associated with regular use of alcohol, drugs, and related substances that affect the central nervous system and personal and social functioning.
(05 Mar 2000)
substance-induced organic mental disorders Mental disorders caused by use of drugs, e.g., cocaine.
(05 Mar 2000)
substance-related disorders These non-psychotic disorders include those related to the taking of a drug of abuse (including alcohol), to the side effects of a medication, and to toxin exposure.
(12 Dec 1998)
delirium, dementia, amnestic, cognitive disorders Cognitive disorders including delirium, dementia, and other cognitive disorders. These may be the result of substance use, trauma, or other causes.
(12 Dec 1998)
disorders, myeloproliferative Tumours of certain bone marrow cells including those that give rise to red cells, granulocytes, and platelets. As opposed to the lymphoproliferative disorders.
(12 Dec 1998)
dissociative disorders Sudden temporary alterations in the normally integrative functions of consciousness.
(12 Dec 1998)
immunodeficiency disorders <radiology> B-cell (antibody) deficiency: high-grade pathogens: pneumococcus, strep, H. Flu, chronic sinopulmonary disease, usual survival to adulthood, T-cell (cellular) deficiency: low-grade pathogens: fungi, viruses, Pneumocystic, growth retardation, diarrhoea, delayed anergy, short life-span, susceptible to graft vs. Host (GvH) disease, e.g.: DiGeorge syndrome, Nezelhof syndrome Note: increased risk of malignancy
(12 Dec 1998)
immunoproliferative disorders Disorders characterised by abnormal proliferation of primary cells of the immune system or by excessive production of immunoglobulins.
(12 Dec 1998)
impulse control disorders Disorders whose essential features are the failure to resist an impulse, drive, or temptation to perform an act that is harmful to the individual or to others. Individuals experience an increased sense of tension prior to the act and pleasure, gratification or release of tension at the time of committing the act.
(12 Dec 1998)
infant nutrition disorders Malnutrition, occurring in infants ages 1 month to 24 months, which is due to insufficient intake of food, dietary nutrients, or a pathophysiologic condition which prevents the absorption and utilization of food. Growth and development are markedly affected.
(12 Dec 1998)
iron metabolism disorders Disorders in the processing of iron in the body: its absorption, transport, storage, and utilization.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • peripheral nervous system
    ¸»ÃÊ ½Å°æ°è
  • point system
    Æ÷ÀÎÆ®½Ä;¸ÍÀοëÀÇ Á¡ÀÚ ¹æ½Ä;ÇÐÁ¡Á¦;¿îÀü À§¹ÝÀÇ Á¡¼öÁ¦
  • premium system
    »ó¿© Á¦µµ(½Ã°£±ÞÀ» Á¤ÇÏ°í ¼ÒÁ¤ ½Ã°£º¸´Ù »¡¸® µÇ¸é ÇÒÁõ ±Þ¿©¸¦ ÁÜ)
  • private-wire system
    »ç¼³ ÀüÈ­(ÅÚ·º½º) ȸ¼±¸Á
  • profit system
    =FREE ENTERPRIZE
  • proportional reserve system
    (Á¤È­ Áغñ¿Í ÁöÆó ¹ßÇà°íÀÇ) ºñ·Ê ÁغñÁ¦
  • protective system
    º¸È£ ¹«¿ª Á¦µµ
  • public address system
    (°­´çµîÀÇ)È®¼º ÀåÄ¡
  • publicaddress system
    È®¼º ÀåÄ¡
  • radar data processing system
    Ç×°ø·Î ·¹ÀÌ´õ Á¤º¸ ó¸® ½Ã½ºÅÛ
  • rationing system
    ¹è±Þ Á¦µµ
  • real-time system
    ½Ç½Ã°£(Áï½Ãó¸®)½Ã½ºÅÛ(´Ü¸»¿¡¼­ º¸³»¿Â µ¥ÀÌÅ͸¦ Áï½Ã ÄÄÇ»ÅÍ¿¡ ó¸®ÇÏ¿© ´Ü¸»·Î µÇµ¹¸®´Â ½Ã½ºÅÛ)
  • remote manipulator system
    ¿ø°Ý Á¶ÀÛ ½Ã½ºÅÛ
  • respiratory system
    È£Èí±â°è
  • reticuloendothelial system
    (¼¼)¸Á ³»(ÇÇ)°è
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 6
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 6
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 6
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 6
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 6
ÅëÇÕ°Ë»ö ¿Ï·á